Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) has provided an announcement.
Innovative Pharmaceutical Biotech Limited has announced a further extension of the long stop dates for its subscription agreements with Zhang Biaobing and Chen Jing. The extension, moving the deadline from August 26, 2025, to September 16, 2025, allows additional time to fulfill the conditions precedent in the agreements. This extension indicates ongoing negotiations and adjustments in the company’s capital-raising efforts, potentially impacting its financial strategy and stakeholder relations.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of medical and biological products. The company is incorporated in the Cayman Islands and continued in Bermuda, with its shares listed on the Hong Kong Stock Exchange.
Average Trading Volume: 21,505,212
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.09B
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.